Regulated growth fails at the handoffs.
WCSSRG helps pharmaceutical, biotech, med device, diagnostics, and life-science organizations align information systems to the way regulated work actually moves: from research hypothesis, to development evidence, to clinical execution, to manufacturing release, to distribution, to patient and customer support.
Capability maps, system roadmaps, investment sequencing, vendor strategy, and executive governance.
GxP impact, Part 11 controls, validation strategy, data integrity, audit trails, retention, and inspection readiness.
Cross-functional architecture connecting R&D, clinical, quality, manufacturing, supply chain, commercial, and support.
Risk-ranked remediation, operating model design, process ownership, and delivery governance that survives real-world execution.
Turn scientific activity into usable, traceable knowledge.
Research organizations create valuable data long before anyone calls it regulated. That is exactly when the future mess starts. WCSSRG helps establish the systems, data model, and governance needed to preserve experiment context, sample lineage, methods, decisions, and intellectual property without crushing scientific velocity.
Promising research data often lives across spreadsheets, local drives, instrument exports, notebooks, shared folders, and tribal knowledge. That makes portfolio decisions slower and downstream development weaker.
A research information architecture that connects experiments, materials, instruments, results, protocols, metadata, and decision history into a usable evidence base.
Better target selection, cleaner tech transfer, stronger IP defensibility, lower rework, and a foundation for AI-enabled discovery that does not depend on garbage-context data.
Build the bridge from promising science to controlled execution.
Development is where informal research patterns start becoming regulatory commitments. We help align formulation, analytical development, method validation, stability, preclinical evidence, device design history, and CMC readiness with the information systems that will carry the product forward.
Development teams often move faster than their operating model. Specifications, studies, methods, materials, requirements, and design decisions become disconnected across functions.
A systems roadmap that links product knowledge, requirements, studies, documents, methods, stability data, and development milestones into a governed development backbone.
Cleaner handoffs to clinical, regulatory, quality, and manufacturing, with fewer late-stage surprises caused by undocumented assumptions or fragmented evidence.
Make clinical data, documents, vendors, and oversight inspection-ready by design.
Clinical execution is an information supply chain. Protocols, sites, subjects, vendors, monitoring, safety events, source data, essential documents, and TMF artifacts must reconcile into a defensible story. WCSSRG helps sponsors and clinical teams connect CTMS, eTMF, EDC, safety, analytics, and vendor oversight into one operating model.
Clinical teams can appear “green” in dashboards while essential documents, protocol deviations, vendor evidence, data corrections, and oversight artifacts quietly drift out of alignment.
A clinical systems and evidence-control model that maps data sources, document obligations, vendor responsibilities, inspection risks, and executive oversight metrics.
Earlier detection of evidence gaps, better CRO/vendor accountability, cleaner TMF health, and stronger readiness for audits, inspections, diligence, and submission support.
Move beyond “compliance tools” into an integrated control environment.
FDA-regulated organizations do not need a pile of disconnected point solutions pretending to be a quality system. They need clear process ownership, validated system boundaries, audit trails, training controls, document lifecycle, issue management, CAPA, change control, risk management, and regulatory commitments connected to the business.
Compliance breaks when Quality owns the procedure, IT owns the platform, the business owns the work, and no one owns the end-to-end control outcome.
A practical regulated-systems framework covering GxP impact, Part 11 applicability, validation approach, data integrity, access governance, record retention, audit readiness, and lifecycle support.
Fewer audit surprises, clearer accountability, stronger inspection posture, better system adoption, and a roadmap that balances risk reduction with business throughput.
Scale the process without losing the evidence.
Manufacturing scale-up is not “just add capacity.” It is a controlled information problem spanning materials, recipes, equipment, batch records, deviations, environmental monitoring, QC testing, release, maintenance, calibration, and supplier quality. WCSSRG helps align GMP operations with the systems needed to prove control.
As organizations scale, manufacturing data, QC results, deviations, equipment records, and release decisions can splinter across systems. That makes quality events slower and product disposition harder.
A manufacturing systems architecture that connects ERP, MES, LIMS, automation data, quality events, master data, batch genealogy, and release workflows.
Better right-first-time execution, faster investigation cycles, improved batch release confidence, stronger supplier visibility, and cleaner alignment with GMP expectations.
Protect the product after it leaves your walls.
Distribution is where product identity, custody, temperature, location, trading partner data, order flow, returns, recalls, and exceptions all become part of the regulated story. WCSSRG helps connect supply chain execution with quality, regulatory, customer, and patient impact.
Supply chain teams optimize movement. Quality teams need proof. Commercial teams need availability. Patients need safety. Disconnected systems make all four harder.
A distribution information model that maps product traceability, partner data exchange, temperature evidence, inventory visibility, returns, exception handling, and recall readiness.
Improved supply chain resilience, stronger product traceability, faster field actions, better customer trust, and fewer blind spots between operations and compliance.
Close the loop between real-world use and regulated action.
The lifecycle does not end at shipment. Complaints, adverse events, medical information requests, device service, product quality issues, warranty data, field actions, and patient support interactions are high-value signals. WCSSRG helps connect those signals back into Quality, Regulatory, Safety, Manufacturing, and Product leadership.
Customer and patient signals are often trapped in support workflows, while Quality and Safety teams need timely, classified, traceable, and reportable information.
A postmarket systems design that connects intake, triage, complaint handling, adverse event routing, investigation, regulatory reporting, field service, knowledge management, and trend analytics.
Faster escalation, better patient and customer experience, stronger postmarket surveillance, improved recall readiness, and a closed-loop operating model for continuous improvement.
Ready to stop managing regulated systems as disconnected islands?
WCSSRG can help you assess the current state, expose the risk, build the roadmap, and guide execution from R&D through customer and patient support.